Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 122,030,624
  • Shares Outstanding, K 258,102
  • Annual Sales, $ 9,869 M
  • Annual Income, $ 3,620 M
  • EBIT $ -349 M
  • EBITDA $ -167 M
  • 60-Month Beta 0.39
  • Price/Sales 12.32
  • Price/Cash Flow 32.48
  • Price/Book 8.31

Options Overview Details

View History
  • Implied Volatility 37.19% ( -0.68%)
  • Historical Volatility 20.08%
  • IV Percentile 99%
  • IV Rank 96.63%
  • IV High 37.87% on 11/01/24
  • IV Low 17.64% on 05/16/24
  • Put/Call Vol Ratio 0.86
  • Today's Volume 4,003
  • Volume Avg (30-Day) 1,795
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 37,152
  • Open Int (30-Day) 39,469

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 32 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 3.68
  • Number of Estimates 11
  • High Estimate 4.33
  • Low Estimate 3.21
  • Prior Year 3.57
  • Growth Rate Est. (year over year) +3.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
447.70 +5.61%
on 10/07/24
499.09 -5.27%
on 10/17/24
+17.49 (+3.84%)
since 10/04/24
3-Month
447.70 +5.61%
on 10/07/24
500.25 -5.49%
on 08/30/24
-21.66 (-4.38%)
since 08/02/24
52-Week
341.90 +38.29%
on 11/16/23
510.64 -7.41%
on 08/01/24
+96.60 (+25.68%)
since 11/03/23

Most Recent Stories

More News
My 2 Favorite Growth Stocks to Buy Hand Over Fist in November

The sky's the limit for these stocks.

VRTX : 472.80 (+0.36%)
AMZN : 195.78 (-1.09%)
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript

VRTX earnings call for the period ending September 30, 2024.

VRTX : 472.80 (+0.36%)
Vertex: Q3 Earnings Snapshot

Vertex: Q3 Earnings Snapshot

VRTX : 472.80 (+0.36%)
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers

It won't be able to be profitable without hitting its targets for both of these figures.

CRSP : 50.59 (-0.33%)
VRTX : 472.80 (+0.36%)
Canada Jobs on Agenda for Next Week

Monday U.S. Economic Lookahead Factory orders (Sept.) Featured Earnings Vertex Pharmaceuticals ...

APO : 139.43 (-1.11%)
PBR : 13.18 (+0.53%)
ANET : 394.88 (+0.18%)
NRG : 88.05 (+1.53%)
CEG : 225.95 (-12.46%)
NVO : 109.72 (-1.98%)
VRTX : 472.80 (+0.36%)
ALC.TO : 14.96 (+0.07%)
EMR : 109.81 (+1.24%)
RBA : 85.40 (+0.35%)
CJT.TO : 138.80 (+0.53%)
QCOM : 165.18 (-0.05%)
12 High-Growth Stocks That Could Deliver Parabolic Returns

These 12 innovative companies could deliver exponential returns over the next quarter century.

NVDA : 136.05 (+0.48%)
NVTS : 2.61 (+1.16%)
VRTX : 472.80 (+0.36%)
RKLB : 11.25 (-1.49%)
LUNR : 7.58 (-6.54%)
SERV : 9.45 (-5.88%)
ACHR : 3.24 (-1.22%)
TSLA : 242.84 (-2.47%)
CRSP : 50.59 (-0.33%)
SOUN : 5.09 (-0.97%)
APLD : 5.97 (-7.59%)
TM : 172.70 (-0.08%)
The Smartest Growth Stock to Buy With $500 Right Now

This stock might not be available for under $500 for long.

NVDA : 136.05 (+0.48%)
MELI : 2,063.70 (+0.43%)
TTD : 118.27 (-0.77%)
VRTX : 472.80 (+0.36%)
Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits

Its latest report of clinical data suggests it has a winner on its hands.

VRTX : 472.80 (+0.36%)
Why We Buy Stocks

Is fear of missing out (FOMO) controlling your portfolio?

NVDA : 136.05 (+0.48%)
AVGO : 168.55 (-0.22%)
SPOT : 377.73 (-1.76%)
VRTX : 472.80 (+0.36%)
USHY : 36.99 (+0.22%)
PLD : 113.86 (+0.41%)
RKLB : 11.25 (-1.49%)
SFT.LN : 25.000 (+2.46%)
WINA : 390.11 (+1.41%)
MCD : 292.85 (-0.80%)
CRSP : 50.59 (-0.33%)
SFTBF : 60.0000 (-1.07%)
Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030

There's no need to change a winning formula.

HCA : 363.16 (+1.67%)
VRTX : 472.80 (+0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 482.64
2nd Resistance Point 479.06
1st Resistance Point 475.93
Last Price 472.80
1st Support Level 469.22
2nd Support Level 465.64
3rd Support Level 462.51

See More

52-Week High 510.64
Last Price 472.80
Fibonacci 61.8% 446.18
Fibonacci 50% 426.27
Fibonacci 38.2% 406.36
52-Week Low 341.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar